An update on viral association of human cancers

Archives of Virology

Volumn 158, Issue 7, 2013, Pages 1433-1443

  Zhang, Xiangning ^a   Zhang, Zhe ^c   Zheng, Biying ^a   He, Zhiwei ^a   Winberg, Gösta ^b   Ernberg, Ingemar ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HUMAN; NEOPLASM; PATHOGENICITY; REVIEW; TUMOR VIRUS; VIROLOGY; VIRUS INFECTION;

ANIMALS; HUMANS; NEOPLASMS; ONCOGENIC VIRUSES; VIRUS DISEASES;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; MURINAE;

EID: 84879691903     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1623-9     Document Type: Review

References (96)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P (1995) A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1: 707-708.
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186-1191.
4. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 319: 1096-1100.
5. Rous P (1911) A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13: 397-411.
6. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6: 730-755.
7. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J (2003) Seroepidemiology of the human polyomaviruses. J Gen Virol 84: 1499-1504.
8. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M (2006) BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 577: 319-341.
9. Zur Hausen H (2008) Novel human polyomaviruses-Re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123: 247-250.
10. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MAA, Dalianis T, Ramqvist T, Andersson B (2007) Identification of a third human polyomavirus. J Virol 81: 4130-4136.
11. Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB et al (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. Plos Pathog 3: 595-604.
12. Helmbold P, Lahtz C, Enk A, Herrmann-Trost P, Marsch WCh, Kutzner H, Dammann RH (2009) Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma. Mol Carcinog 48: 903-909.
13. Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, Almeida A, Boitier F, Carlotti A, Couturaud B, Dupin N (2009) Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 218: 48-56.
14. de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H (2004) Classification of papillomaviruses. Virology 324: 17-27.
15. Michels KB, Zur Hausen H (2009) HPV vaccine for all. Lancet 374: 268-270.
16. National Notifiable Disease Surveillance Sytem-CDC. Available from: http://www. cdc. gov/osels/ph_surveillance/nndss/nndsshis. htm. Accessed on 04. 9. 2012.
17. Lo EJ, Bell D, Woo JS, Li G, Hanna EY, El-Naggar AK, Sturgis EM (2010) Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 120: 1990-1997.
18. Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Dardari R, Belghmi K, Benchakroun N, El Mzibri M, Khyatti M (2011) Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer 6: 3.
19. Huang CC, Hsiao JR, Yang MW, Wu YH, Hsu KF, Chang Y, Chen CW, Tsai ST, Wei HP, Jin YT (2011) Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan. J Clin Pathol 64: 571-577.
20. Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, Cheng YW, Lee H (2012) Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World J Gastroenterol 18: 4051-4058.
21. Vousden KH, Jat PS (1989) Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins. Oncogene 4: 153-158.
22. Liu X, Clements A, Zhao K, Marmorstein R (2006) Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 281: 578-586.
23. Morris EJ, Dyson NJ (2001) Retinoblastoma protein partners. Adv Cancer Res 82: 1-54.
24. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
25. Perz JF, Armstrong GL, Farrington LA et al (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-538.
26. Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78: 12725-12734.
27. Yen CJ, Lin YJ, Yen CS, Tsai HW, Tsai TF, Chang KY, Huang WC, Lin PW, Chiang CW, Chang TT (2012) Hepatitis B Virus X Protein Upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One 7(7): e41931.
28. Diao J, Garces R, Richardson CD (2001) X protein of hepatitis B virus modulates Cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12: 189-205.
29. Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 24: 4741-4750.
30. Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L (2000) Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen. Oncogene 19: 1801-1806.
31. Liu J, Lian Z, Han S et al (2006) De-regulation of E-Cadherin by hepatitis B virus × antigen in hepatocellular carcinoma. Oncogene 16: 1008-1017.
32. Zhang X, Dong N, Zhang H et al (2005) Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 145: 96-104.
33. Poussin K, Dienes H, Sirma H et al (1999) Expression of mutated Hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 192: 111-118.
34. Wang Y, Lau SH, Sham JST et al (2004) Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated x gene and hepatocellular carcinogenesis. Oncogene 23: 142-148.
35. Sze KM, Chu GK, Lee JM, Ng IO (2012) C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c-jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 57: 131-139.
36. Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY (2012) Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine-treated HBx transgenic mice. Hepatology 55: 108-120.
37. Liang TJ, Heller T (2004) Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127: S62-S71.
38. Jopling CL, Yi M, Lancaster AM et al (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
39. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 80: 11082-11093.
40. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
41. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
42. Samols MA, Renne R (2006) Virus-encoded microRNAs: a new chapter in virus-host cell interaction. Future Virol 1: 233-242.
43. Sullivan CS, Ganem D (2005) MicroRNAs and viral infection. Mol Cell 20: 3.
44. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2: e23.
45. Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12: 733-750.
46. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T (2004) Identification of virus-encoded microRNAs. Science 304: 734-736.
47. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102: 5570-5575.
48. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
49. Samols MA, Hu J, Skalsky RL, Renne R (2005) Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79: 9301-9305.
50. Cai X, Hagedorn CH, Cullen BR (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10: 1957-1966.
51. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432: 231-235.
52. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240.
53. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
54. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK et al (2006) Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125: 887-901.
55. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U (2004) Nuclear export of microRNA precursors. Science 303: 95-98.
56. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
57. Salzman DW, Shubert-Coleman J, Furneaux H (2007) P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. J Biol Chem 282: 32773-32779.
58. Khvorova A, Reynolds A, Jayasena SD (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115: 209-216.
59. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208.
60. Skalsky RL, Samols MA, Karlie B, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R (2007) Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155. J Virol 81: 12836-12845.
61. Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) MicroRNA-155 targets SMAD2and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 285: 41328-41336.
62. Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC (2010) Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA 107: 3111-3116.
63. Yin Q et al (2008) MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82: 5295-5306.
64. Yin Q et al (2010) MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol 84: 6318-6327.
65. Liu Y et al (2012) Kaposi's Sarcoma-Associated Herpesvirus-Encoded MicroRNA miR-K12-11 Attenuates Transforming Growth Factor Beta Signaling through Suppression of SMAD5. J Virol 86: 1372.
66. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97: 6055-6060.
67. Allday MJ (2009) How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma? Semin Cancer Biol 19: 366-376.
68. Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5: 423-428.
69. Chen J, Fu L, Zhang LY, Kwong DL, Yan L, Guan XY (2012) Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer 31: 215-222.
70. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61: 3877-3881.
71. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q (2004) The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21. 3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23: 4793-4806.
72. Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25: 1070-1080.
73. Du C, Huang T, Sun D, Mo Y, Feng H, Zhou X, Xiao X, Yu N, Hou B, Huang G, Ernberg I, Zhang Z (2011) CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett 309: 54-61.
74. Zhang X, Liu H, Li B, Huang P, Shao J, He Z (2012) Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter. BMC Cancer 12: 267. doi: 10. 1186/1471-2407-12-267.
75. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69: 1051-1065.
76. Pathmanathan R, Prasad U et al (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333: 693-698.
77. Pak MW, To KF et al (2002) Nasopharyngeal carcinoma in situ (NPCIS)-pathologic and clinical perspectives. Head Neck 24: 989-995.
78. Cheung FM, Pang SW et al (2004) Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential. Histopathology 45: 171-179.
79. Chan AS, To KF et al (2000) High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60: 5365-5370.
80. Chan AS, To KF et al (2002) Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 102: 300-303.
81. Liu XQ, Chen HK et al (2003) Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21. 3, in human nasopharyngeal carcinoma. Int J Cancer 106: 60-65.
82. Chow LS, Lo KW et al (2004) RASSF1A is a target tumor suppressor from 3p21. 3 in nasopharyngeal carcinoma. Int J Cancer 109: 839-847.
83. Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12(6): 431-441.
84. Hu L, Troyanovsky B, Zhang X, Trivedi P, Ernberg I, Klein G (2000) Differences in the immunogenicity of latent membrane protein 1(LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. Cancer Res 60: 5589-5593.
85. Zhang X, Dawson CW, He Z, Huang P (2012) Immune evasion strategies of the human gamma-herpesviruses: implications for viral tumorigenesis. J Med Virol 84: 272-281.
86. Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW (2004) Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23: 4488-4494.
87. Lo AK et al (2010) Upregulation of Id1 by Epstein-Barr virus-encoded LMP1 confers resistance to TGFbeta-mediated growth inhibition. Mol Cancer 9: 155.
88. Floettmann JE, Ward K, Rickinson AB, Rowe M (1996) Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223: 29-40.
89. Deng W, Pang PS, Tsang CM, Hau PM, Yip YL, Cheung ALM, Tsao SW (2012) Epstein-Barr virus-encoded latent membrane Protein 1 Impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation. PLoS ONE 7: e39095.
90. Gruhne B, Kamranvar SA, Masucci MG, Sompallae R (2009) EBV and genomic instability-a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma. Sem Cancer Biol 19: 394-400.
91. Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG (2009) The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA 106: 2313-2318.
92. Kamranvar SA, Gruhne B, Szeles A, Masucci MG (2007) Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma. Oncogene 26: 5115-5123.
93. Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liu FF (2002) Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res 62: 171-178.
94. Zuo Y, Wu J, Xu Z, Yang S, Yan H, Tan L, Meng X, Ying X, Liu R, Kang T, Huang W (2011) Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma. PLoS One. 6e19407.
95. Carbone M, Klein G, Gruber J, Wong M (2004) Modern criteria to establish human cancer etiology. Cancer Res 64: 5518-5524.
96. Zur Hausen H (2012) Red meat consumption and cancer: reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int J Cancer 130: 2475-2483.